FDA Panel Rejects Lilly’s Cancer Drug Tested Only in Chinanews2022-02-10T22:41:51+00:00February 10th, 2022|The New York Times|
The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Oldernews2021-12-22T22:02:31+00:00December 22nd, 2021|The New York Times|
Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysisnews2021-12-15T02:22:07+00:00December 15th, 2021|The New York Times|
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
New Covid Antiviral Pills Offer Hope as Omicron Loomsnews2021-12-07T08:00:09+00:00December 7th, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked.news2021-11-27T17:41:57+00:00November 27th, 2021|The New York Times|
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drugnews2021-11-22T16:00:09+00:00November 22nd, 2021|The New York Times|
